Simon Langdon

Citée par

	Toutes	Depuis 2020
Citations	12661	3696
indice h	62	31
indice i10	166	71

820

410

205

615

198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202533 53 45 53 40 48 35 57 83 91 79 122 160 129 172 198 206 226 188 210 224 262 249 293 331 401 468 486 621 625 665 701 646 632 686 804 795 680 640 90

Accès public

Tout afficher

38 articles

7 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

David J HarrisonUniversity of St AndrewsAdresse e-mail validée de nucana.com
Andrew H SimsUniversity of EdinburghAdresse e-mail validée de ed.ac.uk
John BartlettDirector of Transformative Pathology, Ontario Institute for Cancer ResearchAdresse e-mail validée de oicr.on.ca
Alistair WilliamsDepartment of Pathology, University of EdinburghAdresse e-mail validée de ed.ac.uk
Yusuf DeeniProfessor of Molecular Biology and Biomedicine, Department of Microbiology and BiotechnologyAdresse e-mail validée de abertay.ac.uk
V Anne SmithSchool of Biology, University of St AndrewsAdresse e-mail validée de st-andrews.ac.uk
Hilal Shahid KhalilMS| PhD | MLS (ASCP)Adresse e-mail validée de bhmcny.org
Antonis KoussounadisUniversity of St AndrewsAdresse e-mail validée de st-andrews.ac.uk
Oystein fodstadProfessor emeritus, Oslo University Hospital, University of OsloAdresse e-mail validée de rr-research.no
Igor GoryaninHenrik Kacser Chair in Systems BiologyAdresse e-mail validée de inf.ed.ac.uk
Charlotte K Y NgHumanitas University and University of BernAdresse e-mail validée de unibe.ch
Robert ClarkeThe Hormel Institute, University of MinnesotaAdresse e-mail validée de umn.edu
Sarah J AitkenYale University (US) & University of Cambridge (UK)Adresse e-mail validée de yale.edu
Anatoly SorokinOkinawa Institute of Science and TechnologyAdresse e-mail validée de oist.jp
Epie BovenHoogleraar Medische Oncologie, VUmc, AmsterdamAdresse e-mail validée de vumc.nl
Amanda O'DonnellMolecular Cancer Studies, University of ManchesterAdresse e-mail validée de manchester.ac.uk
TOSHIYASU TANIGUCHIFred Hutchinson Cancer Research Center, Tokai University School of MedicineAdresse e-mail validée de umin.ac.jp
Alexey LarionovLecturer in Bioinformatics, Cranfield University, UKAdresse e-mail validée de cranfield.ac.uk
Adrian L HarrisProfessor of Medical Oncology, Oxford UniversityAdresse e-mail validée de oncology.ox.ac.uk
Elad KatzUniversity of DundeeAdresse e-mail validée de dundee.ac.uk

Suivre

Simon Langdon

University of Edinburgh, Reader

Adresse e-mail validée de ed.ac.uk - Page d'accueil

Cancer research


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system A Koussounadis, SP Langdon, IH Um, DJ Harrison, VA Smith Scientific reports 5 (1), 10775, 2015	747	2015
Antitumor Activity and Pharmacokinetics in Mice of 8-Carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a Novel Drug … MFG Stevens, JA Hickman, SP Langdon, D Chubb, L Vickers, R Stone, ... Cancer research 47 (22), 5846-5852, 1987	552	1987
Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer SA Eccles, EO Aboagye, S Ali, AS Anderson, J Armes, F Berditchevski, ... Breast Cancer Research 15, 1-37, 2013	537	2013
Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma W Sakai, EM Swisher, C Jacquemont, KV Chandramohan, FJ Couch, ... Cancer research 69 (16), 6381-6386, 2009	369	2009
Characterization and properties of nine human ovarian adenocarcinoma cell lines SP Langdon, SS Lawrie, FG Hay, MM Hawkes, A McDonald, IP Hayward, ... Cancer research 48 (21), 6166-6172, 1988	315	1988
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer JMS Bartlett, SP Langdon, BJB Simpson, M Stewart, D Katsaros, ... British journal of cancer 73 (3), 301-306, 1996	261	1996
Quantitative analysis of changes in ER, PR and HER2 expression in primary breast cancer and paired nodal metastases SJ Aitken, JS Thomas, SP Langdon, DJ Harrison, D Faratian Annals of Oncology 21 (6), 1254-1261, 2010	257	2010
Antiestrogen therapy is active in selected ovarian cancer cases: the use of letrozole in estrogen receptor–positive patients JF Smyth, C Gourley, G Walker, MJ MacKean, A Stevenson, ... Clinical Cancer Research 13 (12), 3617-3622, 2007	240	2007
New strategies for targeting the hypoxic tumour microenvironment in breast cancer C Ward, SP Langdon, P Mullen, AL Harris, DJ Harrison, CT Supuran, ... Cancer treatment reviews 39 (2), 171-179, 2013	232	2013
CA125 response is associated with estrogen receptor expression in a phase II trial of letrozole in ovarian cancer: identification of an endocrine-sensitive subgroup A Bowman, H Gabra, SP Langdon, A Lessells, M Stewart, A Young, ... Clinical cancer research 8 (7), 2233-2239, 2002	213	2002
Estrogen receptor-α mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen AJM O’Donnell, KG Macleod, DJ Burns, JF Smyth, SP Langdon Endocrine-related cancer 12 (4), 851-866, 2005	203	2005
Genomic analysis of genetic heterogeneity and evolution in high-grade serous ovarian carcinoma SL Cooke, CKY Ng, N Melnyk, MJ Garcia, T Hardcastle, J Temple, ... Oncogene 29 (35), 4905-4913, 2010	199	2010
Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab D Faratian, A Goltsov, G Lebedeva, A Sorokin, S Moodie, P Mullen, C Kay, ... Cancer research 69 (16), 6713-6720, 2009	198	2009
A comparative analysis of inhibitors of the glycolysis pathway in breast and ovarian cancer cell line models C Xintaropoulou, C Ward, A Wise, H Marston, A Turnbull, SP Langdon Oncotarget 6 (28), 25677, 2015	193	2015
Growth of Small Cell Lung Cancer Cells: Stimulation by Multiple Neuropeptides and Inhibition by Broad Spectrum Antagonists in Vitro and in Vivo T Sethi, S Langdon, J Smyth, E Rozengurt Cancer Research 52 (9_Supplement), 2737s-2742s, 1992	186	1992
Cancer cell culture SP Langdon Humana 5 (9), 2010	185	2010
Altered ErbB receptor signaling and gene expression in cisplatin-resistant ovarian cancer K Macleod, P Mullen, J Sewell, G Rabiasz, S Lawrie, E Miller, JF Smyth, ... Cancer research 65 (15), 6789-6800, 2005	176	2005
Expression of the heat shock protein HSP27 in human ovarian cancer. SP Langdon, GJ Rabiasz, GL Hirst, RJ King, RA Hawkins, JF Smyth, ... Clinical cancer research: an official journal of the American Association …, 1995	175	1995
Implantable biosensors and their contribution to the future of precision medicine M Gray, J Meehan, C Ward, SP Langdon, IH Kunkler, A Murray, D Argyle The Veterinary Journal 239, 21-29, 2018	147	2018
High antitumour activity of ET743 against human tumour xenografts from melanoma, non-small-cell lung and ovarian cancer HR Hendriks, HH Fiebig, R Giavazzi, SP Langdon, JM Jimeno, ... Annals of Oncology 10 (10), 1233-1240, 1999	145	1999

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs